Resolute Capital Asset Partners’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-51,106
Closed -$1.95M 52
2026
Q1
$1.95M Buy
+51,106
New +$1.62M 1.03% 32
2023
Q3
Sell
-45,489
Closed -$1.44M 34
2023
Q2
$1.44M Sell
45,489
-27,700
-38% -$895K 1.02% 33
2023
Q1
$2.42M Sell
73,189
-19,456
-21% -$637K 1.77% 25
2022
Q4
$2.98M Sell
92,645
-14,500
-14% -$494K 2.66% 19
2022
Q3
$3.83M Sell
107,145
-55,201
-34% -$2.29M 3.43% 6
2022
Q2
$6.67M Buy
162,346
+14,000
+9% +$680K 4.79% 6
2022
Q1
$8.59M Sell
148,346
-60,929
-29% -$3.33M 5.49% 4
2021
Q4
$12.3M Buy
+209,275
New +$12.7M 8.03% 2

Other funds holding ATEX

Resolute Capital Asset Partners's ATEX Position: Q2 2026 in Review

Resolute Capital Asset Partners sold out of Anterix (ATEX) in Q2 2026, closing a stake of 51,106 shares — an estimated $1.95M sold.

Resolute Capital Asset Partners first reported a position in ATEX in Q4 2021 and held it in 8 quarters. The position peaked at $12.3M in Q4 2021. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Resolute Capital Asset Partners reported no remaining Anterix position as of Q2 2026 after selling out during the quarter.
  • Resolute Capital Asset Partners sold 51,106 Anterix shares in Q2 2026, an estimated $1.95M.
  • Resolute Capital Asset Partners first reported a position in Anterix in Q4 2021 and held it in 8 quarters.
  • Resolute Capital Asset Partners's Anterix position peaked at $12.3M in Q4 2021.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Resolute Capital Asset Partners's 13F filing for Q2 2026, filed 14 Aug 2026.